1[1]Peto J. Cancer epidemiology in the last century and the next decade. Nature,2001,411 (6835) :390-395.
2[2]Shigetoshi F, Motohiko T, Seishi M, et al. Tumor markers in early diagnosis,follow-up and management of patients with hepatocellular carcinoma. Oncol-ogy, 2002,62( S1 ): 57-63.
3[5]Yoshida-S, Kurokohchi-K, Arima-K, et al. Clinical significance of lens culinaris agglutinin-reactive fraction of of serum alpha-fetoprotein in patients with hepatocdlular carcinoma. Int J Oncol, 2002,20(2): 305-309.
4[6]Khien VV, Mao HV, Chinh TT, et al. Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma. Int Biol Markers, 2001,16(2): 105-111.
5[7]Yamashiki N ,Seki T,Wakabayaahi M,et al. Usefulness of Lens culinaris agglutinin A-reactive fraction of alpha-fetoprotein (AFP-L3) as a marker of distant metastasis from hepatocellular carcinoma. Oncol Rep, 1999,6 (6):1229-1232.
6[8]Hayashi K, Kumada T, Nakano S, et al. Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma. Am J Gastroenterol,1999,94 (10): 2028-3033.
7[9]Kumada T, Nakano S, Takeda T, et al. Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis. J Hepatol, 1999,30( 1 ): 125-130.
8[10]Oka H, Saito A, Ito K, et al. Multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Les culinaris agglutinin-reactive alpha-fetoprotein. J Gastroent Hepatol, 2001, 16(12): 1378-1383.
9[11]Li D, Mallory T, Satomura S. AFP-L3: a new generation of tumor marker for hepatocellular carcinoma. Clin Chim Acta, 2001,313 ( 1-2 ): 15-19.
10[12]I Jichi M, Takayama T, Matsumura M, et al. Alpha-fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma; a prospective study. Hepatology, 2002,35 (4): 835-860.
6Zhi-Zhen Dong,Deng-Fu Yao,Min Yao,Li-Wei Qiu,Lei Zong,Wei Wu, Xin-Hua Wu,Deng-Bing Yao and Xian-Yong Meng Department of Diagnostics,Research Center of Clinical Molecular Biology,Department of Laboratory Science,and Department of GastroenterologyAffiliated Hospital,and Institute of Neurosciences,Nantong University,Nantong 226001,China.Clinical impact of plasma TGF-β1 and circulating TGF-β1 mRNA in diagnosis of hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2008,7(3):288-295. 被引量：27
3Ryder SD, British Society of Gastroenterology. Guidelines for the diagnosis and treatment to hepatocellular carcinoma (HCC) in adults[J]. Gut, 2003,52(Suppl 3):1-8.
4Choi BY, Nguyen MH. The diagnosis and management of benign hepatic tumors [J]. J Clin Gastroenterol, 2005, 39(5): 401-412.
5Tajima T, Funakoshi A, Ikeda Y, et al. Nonfunctioning adrenal rest tumor of the liver: radiologic appearance [J]. J Comput Assist Tomogr, 2001, 25 ( 1 ): 98-101.
